Detalhe da pesquisa
1.
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study.
Br J Pharmacol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773354
2.
Angptl3 regulates lipid metabolism in mice.
Nat Genet
; 30(2): 151-7, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11788823
3.
Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
J Pharmacol Sci
; 115(3): 329-35, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350313
4.
Liver X receptor agonists inhibit tissue factor expression in macrophages.
FEBS J
; 272(6): 1546-56, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15752369
5.
High glucose potentiates palmitate-induced NO-mediated cytotoxicity through generation of superoxide in clonal beta-cell HIT-T15.
FEBS Lett
; 545(2-3): 219-23, 2003 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-12804779
6.
Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
Pancreas
; 24(2): 184-90, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11854624
7.
Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Eur J Pharmacol
; 623(1-3): 141-7, 2009 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19765581
8.
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Eur J Pharmacol
; 601(1-3): 192-7, 2008 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19014931
9.
Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry.
Anal Chem
; 77(7): 2050-5, 2005 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15801737
10.
Synthesis and biological activity of novel alpha-substituted beta-phenylpropionic acids having pyridin-2-ylphenyl moiety as antihyperglycemic agents.
Bioorg Med Chem
; 12(9): 2419-39, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15080938